Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 52,670	$ 46,729
Accounts receivable, net of allowances of $275 and $416	10,098	9,737
Inventory	12,781	13,162
Prepaid expenses and other current assets	2,522	2,098
Total current assets	78,071	71,726
Property and equipment, net	2,341	1,984
Intangible assets, net	1,739	2,119
Right-of-use assets	1,738	1,954
Other long-term assets	2,276
Deferred tax asset, net	140
Restricted cash	265	265
Total assets	86,570	78,048
Current liabilities:
Accounts payable	2,147	1,667
Accrued expenses and other current liabilities	13,451	15,300
Total current liabilities	15,598	16,967
Long-term debt	41,124	40,515
Other long-term liabilities	1,390	1,685
Total liabilities	58,112	59,167
Commitments and contingencies (Note 12)
Stockholders' equity:
Preferred stock; $0.001 par value: 10,000,000 shares authorized; no shares issued and outstanding
Common stock; $0.001 par value: 200,000,000 shares authorized; 39,395,712 and 24,494,675 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively	39	24
Additional paid-in capital	387,059	339,655
Accumulated other comprehensive income	90	91
Accumulated deficit	(358,730)	(320,889)
Total stockholders' equity	28,458	18,881
Total liabilities and stockholders' equity	$ 86,570	$ 78,048